Life Sciences and Healthcare

Transforming health together

img

Working with the most innovative, venture-backed businesses and their investors, we’re here to do all we can to supercharge your growth. From personal support by our team of early-stage specialists to helpful advice and connections to key ecosystem players, we’re helping to open up a world of opportunity.

A strategic partner to your business

1

Dedicated team

Our Life Science & Healthcare team hold sector expertise across biopharma, digital health, medical devices, diagnostics, tools and healthcare services. The team partners with all stages of businesses from seed to large public companies.

2

Industry perspective

We have extensive experience across healthcare, life sciences and innovation and seek to share that knowledge in the form of regular dedicated research, proprietary content and events.

3

Financing solutions

We offer bespoke and varied lending solutions that scale with your business, including venture debt, cash flow lending and structured finance, to help you achieve your goals.

4

Bespoke

We act quickly and can flex to the evolving needs of a fast-growing company to ensure you seize opportunities in an ever-changing market. Our team of experts have worked with numerous companies and understand that every growth journey is different so can adapt to various requirements.

5

International capabilities

We can support your business with liquidity, banking and foreign exchange solutions for your international expansion.

6

Ecosystem relationships

Our established relationships and teams in the UK, US, Sweden, Denmark, Israel and Hong Kong could help accelerate your global development.

img

Venture Healthcare Report 2024

In 2023, venture healthcare faced a challenging IPO market and limited M&A opportunities, grappling with the valuation and investment froth from 2020-1H 2022. However, 1H 2024 saw increased investment across every sector and numerous new investor-led financings.

Latest insights from the team

1

UK HealthTech: Crossing the Series A Chasm

This blog and short report explore the apparent disconnect from the traditional venture fundraising pathway for healthtechs between Series A and Series B.
2

Venture debt: Timing is everything

Venture debt can accelerate growth, but it’s important to choose the right time to take debt on. Here are some key questions to ask if you’re considering debt.
3

Venture Capital Term Sheet Guide 2024

Insights from over 425 anonymised, final term sheets to empower the ecosystem with clarity about the market standard.

Your dedicated team

Meet the Life Sciences and Healthcare team

Our specialist team is full of brilliant, knowledgeable people dedicated to creating a bespoke path for all our clients and investors.

mike white

Michael White

Head of Life Sciences & Healthcare

Our Products

Want to know more?

Get in touch to see how we can help you scale at speed.
fscs